• LAST PRICE
    0.4613
  • TODAY'S CHANGE (%)
    Trending Up0.0169 (3.8029%)
  • Bid / Lots
    0.4401/ 5
  • Ask / Lots
    0.4799/ 2
  • Open / Previous Close
    0.4440 / 0.4444
  • Day Range
    Low 0.4400
    High 0.4820
  • 52 Week Range
    Low 0.4121
    High 2.3900
  • Volume
    262,767
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.4444
TimeVolumeCDTX
09:32 ET69780.45
09:34 ET19000.444
09:38 ET4030.444
09:50 ET1700.456026
09:59 ET58800.4451
10:01 ET25250.444
10:03 ET396920.482
10:10 ET10000.4819
10:14 ET43520.46
10:15 ET10000.445
10:17 ET5000.4499
10:19 ET50000.44
10:26 ET3810.44
10:28 ET158260.4621
10:30 ET3000.469
10:33 ET11000.442
10:37 ET1000.442
10:44 ET1000.444
10:46 ET5750.4425
10:48 ET2000.469
10:50 ET35000.4527
11:18 ET18000.46
11:54 ET5000.46495
12:25 ET20000.46
12:27 ET13500.4647
12:30 ET96540.4694
12:36 ET10000.4693
12:50 ET1000.46465
12:54 ET1000.46
12:56 ET10000.46
12:59 ET19000.4606
01:08 ET12000.4568
01:14 ET5000.4593
01:21 ET25000.456
01:24 ET1000.4606
01:37 ET100000.46
01:46 ET32990.4605
01:48 ET23000.46
02:04 ET50800.46325
02:13 ET3500.4576
02:18 ET84500.46325
02:20 ET30000.4689
02:22 ET11000.469
02:26 ET5000.4689
02:29 ET13000.46325
02:31 ET3000.4613
02:36 ET49000.4613
02:38 ET2500.4649
02:47 ET5000.46115
02:49 ET10000.46115
02:51 ET10000.4575
02:54 ET10100.4575
02:56 ET2000.4575
02:58 ET3000.4575
03:02 ET7500.4542
03:05 ET5000.4421
03:12 ET20000.4431
03:14 ET333000.4648
03:18 ET212000.46
03:21 ET3000.4624
03:23 ET13000.4648
03:25 ET12000.46
03:27 ET1000.4647
03:30 ET55730.4624
03:41 ET5000.4621
03:43 ET60580.4612
03:45 ET109780.4609
03:52 ET7040.4614
03:54 ET8000.4616
03:56 ET35150.4618
03:57 ET70000.4613
03:59 ET15060.4613
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCDTX
Cidara Therapeutics Inc
30.7M
-0.7x
---
United StatesALIM
Alimera Sciences Inc
35.1M
-5.3x
---
United StatesOPNT
Opiant Pharmaceuticals Inc
71.3M
30.4x
---
United StatesJAN
Janone Inc
5.7M
-0.4x
---
United StatesRMTI
Rockwell Medical Inc
14.2M
-4.8x
---
United StatesBIOQ
Bioqual Inc
62.6M
11.4x
+17.04%
As of 2022-05-23

Company Information

Cidara Therapeutics, Inc. is a biotechnology company. The Company is focused on the discovery, development and commercialization of therapeutics designed for the care of patients facing serious fungal or viral infections. The Company's lead product candidate is rezafungin acetate, an intravenous formulation of an echinocandin. Rezafungin is being developed as a once-weekly, high-exposure therapy for the treatment and prevention of serious invasive fungal infections. Rezafungin acetate is in Phase III of chemical trials. Its Cloudbreak antiviral platform consist of pipelines to develop Antiviral Conjugates (AVCs) for the prevention and treatment of influenza and other viral infections, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV) and the SARS-CoV-2 strains causing COVID-19. The Company's subsidiary includes Cidara Therapeutics United Kingdom Limited and Cidara Therapeutics (Ireland) Limited.

Contact Information

Headquarters
6310 Nancy Ridge Dr Ste 101SAN DIEGO, CA, United States 92121-3209
Phone
858-752-6170
Fax
302-655-5049

Executives

Independent Chairman of the Board
Daniel Burgess
President, Chief Executive Officer, Chief Financial Officer, Director
Jeffrey Stein
Chief Financial Officer, Chief Business Officer
Preetam Shah
Chief Operating Officer
Paul Daruwala
General Counsel, Corporate Secretary
Jessica Oien

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$30.7M
Revenue (TTM)
$54.3M
Shares Outstanding
69.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.47
EPS
$-0.67
Book Value
$0.32
P/E Ratio
-0.7x
Price/Sales (TTM)
0.6
Price/Cash Flow (TTM)
---
Operating Margin
-77.93%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.